Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin's lymphoma.

Machover, D; Delmas-Marsalet, B; Misra, S C; Gumus, Y; Goldschmidt, E; Schilf, A; Frénoy, N; Emile, J F; Debuire, B; Guettier, C; Farrokhi, P; Boulefdaoui, B; Norol, F; Parquet, N; Ulusakarya, A; Jasmin, C

Machover, D; Delmas-Marsalet, B; Misra, S C; Gumus, Y; Goldschmidt, E; Schilf, A; Frénoy, N; Emile, J F; Debuire, B; Guettier, C; Farrokhi, P; Boulefdaoui, B; Norol, F; Parquet, N; Ulusakarya, A; Jasmin, C.

Affiliation

Machover D; Department of Hematology and Oncology and the Institut du Cancer et d'Immunogénétique (ICIG), Hospital Paul Brousse, Villejuif, France. david.machover@pbr.ap-hop-paris.fr

Ann Oncol ; 12(10): 1439-43, 2001 Oct.

Article de En | MEDLINE | ID: mdl-11762817

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphome malin non hodgkinien / Protocoles de polychimiothérapie antinéoplasique Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Ann Oncol Sujet du journal: NEOPLASIAS Année: 2001 Type de document: Article Pays d'affiliation: France

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links